Dana-Farber Cancer Institute Sales Associate Salaries in Dalton, GA
The average Dana-Farber Cancer Institute Sales Associate in Dalton, GA earns an estimated $75,189 annually, which includes an estimated base salary of $52,835 with a $22,354 bonus. Dana-Farber Cancer Institute's Sales Associate compensation is $17,337 more than the US average for a Sales Associate. Sales Associate salaries at Dana-Farber Cancer Institute in Dalton, GA can range from $26,000 - $214,000.
In Dalton, GA, The Sales Department at Dana-Farber Cancer Institute earns $3,056 more on average than the Marketing Department. Comparably data has a total of 1 salary record from Dana-Farber Cancer Institute Sales Associates.
Last updated 8 months ago.
- $52,835
- avg. base
- $22,354
- avg. bonus
Sales Associate Salaries at Dana-Farber Cancer Institute
In Dalton, GA, Sales Associates earn $9,378 more than Sales Associates, and $45,752 less than Sales Reps.
Compensation at Dana-Farber Cancer Institute by Department
In Dalton, GA, The Sales Department averages $3,056 more than the Marketing Department, and $2,063 less than the HR Department
Recent Sales Associate Salaries at Dana-Farber Cancer Institute
Sales Associate Compensation by Gender (All Companies)
The average female Sales Associate at companies similar size to Dana-Farber Cancer Institute reported making $71,067, while the average male Sales Associate at similar sized companies reported making $75,485.
Sales Associate Compensation by Ethnicity (All Companies)
The average Caucasian Sales Associate at companies similar size to Dana-Farber Cancer Institute reported making $67,913, while the average Native American Sales Associate at similar sized companies reported making $35,000.
How Sales Associates at Dana-Farber Cancer Institute Rate Their Compensation
The majority of Sales Associates at Dana-Farber Cancer Institute believe they're compensated fairly. The vast majority (78%) of Sales Associates at Dana-Farber Cancer Institute are satisfied with their benefits. See more compensation ratings at Dana-Farber Cancer Institute
